Moeller Calls on SCOTUS To Uphold Reproductive Medication Access

ELGIN, Ill. –  State Rep. Anna Moeller, D-Elgin, is continuing her fight to defend the right to choose by joining more than 600 legislators from 49 states in encouraging the U.S. Supreme Court to preserve access to critical reproductive health medications.   

“Extremist politicians and advocates will not stop until they’ve all but eroded the right to choose for women in every corner of this country, but we won’t stop fighting back against that either,” Moeller said. “When legislators from nearly every state are saying ‘we don’t want this’, the Supreme Court and far-right groups should take that as a sign that Americans will not go back. I hope more of my colleagues in Illinois and especially across the aisle join us and resist the anti-choice backsliding.” 

Moeller co-signed an amicus brief to the U.S. Supreme Court urging the high court to reject a right-wing judge’s effort to restrict access to mifepristone, which can be used to end a pregnancy or treat a miscarriage. The judge’s initial ruling would not only diminish a provider’s ability to prescribe mifepristone over the phone, online, or through the mail but also lowered the period in which someone can access the drug. Typically, at-home pregnancy tests are reliable after 4 weeks of a missed menstruation cycle. If the Supreme Court upholds the lower court’s ruling, the time limit would decrease from 10 weeks to 7 weeks. 

Moeller has a strong history of fighting for the right to choose. She passed the Patient and Provider Protection Act, legislation introduced to counter the Supreme Court’s Dobbs ruling to overturn Roe v. Wade. Among other things, the legislation requires public universities make ‘Plan B’ drugs available for purchase, expands reproductive care capacities in rural and underserved communities, and allows patients to receive hormonal birth control over-the-counter.

For more information on Moeller’s advocacy for reproductive rights, visit ilga.gov. 

###